Trials / Sponsors / Fu-Dong Shi
Fu-Dong Shi
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD Neuromyelitis Optica Spectrum Disorders, Neuromyelitis Optica, Devic's Disease | Phase 1 / Phase 2 | 2017-02-01 |